[Experiences with propericiazine in the treatment of functional psychomotor disorders and states of restlessness in childhood].
D000293:Adolescent; D001930:Brain Injuries / Q000150:complications; D002648:Child; D004200:Diseases in Twins; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy* / Q000209:etiology / Q000235:genetics; D008297:Male; D009570:Nitriles / Q000009:adverse effects / Q000627:therapeutic use*; D010640:Phenothiazines / Q000009:adverse effects / Q000627:therapeutic use*; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use*; D011596:Psychomotor Disorders / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D009570:Nitriles; D010640:Phenothiazines; D010880:Piperidines; D014149:Tranquilizing Agents
Erfahrungen mit Propericiazin in der Behandlung kindlicher psychomotorischer Funktionsstörungen und Unruhezustände.